Ilan Linder
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment
Papers in
-
- Epilepsy research and treatment 5
-
- Pharmacological Effects and Toxicity Studies 3
- Pediatric Urology and Nephrology Studies 1
- Co-authors
- Tally Lerman‐Sagie (4 shared papers)Tali Lerman-Sagie (3 shared papers)Shay Menascu (2 shared papers)Uri Kramer (2 shared papers)Omer Bar Yosef (1 shared paper)Michal Tzadok (1 shared paper)Bruria Ben‐Zeev (1 shared paper)Orna Epstein (1 shared paper)
In The Last Decade
Ilan Linder
11 papers receiving 348 citations
Peers
Comparison fields: 5 of 54
- Pharmacology 195
- Psychiatry and Mental health 102
- Cellular and Molecular Neuroscience 93
- Pharmacy 13
- Pediatrics, Perinatology and Child Health 51
Countries citing papers authored by Ilan Linder
This map shows the geographic impact of Ilan Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Linder more than expected).
Fields of papers citing papers by Ilan Linder
This network shows the impact of papers produced by Ilan Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Linder. The network helps show where Ilan Linder may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilan Linder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 181 | |
| 2 | 2018 | 50 | |
| 3 | 2016 | 45 | |
| 4 | 2007 | 29 | |
| 5 | 2012 | 22 | |
| 6 | 2011 | 20 | |
| 7 | 2022 | 8 | |
| 8 | 2024 | 4 | |
| 9 | Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE. | 2020 | 2 |
| 10 | 2022 | 1 | |
| 11 | 2017 | 1 | |
| 12 | 2022 | 0 |
About Ilan Linder
Ilan Linder is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Pharmacology, Parasitology and Genetics, having authored 12 papers that have together received 363 indexed citations. Recurring topics across this work include Epilepsy research and treatment (5 papers), Cannabis and Cannabinoid Research (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), Pediatric Urology and Nephrology Studies (1 paper), Glycogen Storage Diseases and Myoclonus (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and Bartonella species infections research (1 paper). The work is most often cited by research in Pharmacology (195 citations), Psychiatry and Mental health (102 citations), Cellular and Molecular Neuroscience (93 citations), Pharmacy (13 citations) and Pediatrics, Perinatology and Child Health (51 citations). Ilan Linder has collaborated with scholars based in Israel, Belgium and Australia. Frequent co-authors include Tally Lerman‐Sagie, Tali Lerman-Sagie, Shay Menascu, Uri Kramer, Omer Bar Yosef, Michal Tzadok, Bruria Ben‐Zeev, Orna Epstein, Dorit Granot and Lubov Blumkin. Their work appears in journals such as Journal of Child Neurology, European Journal of Paediatric Neurology, Epilepsia, Epileptic Disorders and Seizure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.